Hadasit Bio (HDST) - Total Liabilities

Latest as of June 2023: ILA3.73 Million ILA ≈ $9.99K USD

Based on the latest financial reports, Hadasit Bio (HDST) has total liabilities worth ILA3.73 Million ILA (≈ $9.99K USD) as of June 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Hadasit Bio long-term investment allocation to see how much of total assets are deployed in long-term investments.

Hadasit Bio - Total Liabilities Trend (2008–2022)

This chart illustrates how Hadasit Bio's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Hadasit Bio asset portfolio.

Hadasit Bio Competitors by Total Liabilities

The table below lists competitors of Hadasit Bio ranked by their total liabilities.

Company	Country	Total Liabilities
Spectra Inc. V:SSA	Canada	CA$201.28K
Thai Polycons Public Company Limited BK:TPOLY	Thailand	฿5.87 Billion
Camellia Plc LSE:CAM	UK	GBX128.80 Million
France Tourisme Immobilier SA PA:MLFTI	France	€6.94 Million
Northern Venture Trust LSE:NVT	UK	GBX208.00K
RareX Limited F:CK1	Germany	€1.01 Million
Crest Nicholson Holdings plc LSE:CRST	UK	GBX694.40 Million

Liability Composition Analysis (2008–2022)

This chart breaks down Hadasit Bio's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See HDST equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hadasit Bio's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hadasit Bio (2008–2022)

The table below shows the annual total liabilities of Hadasit Bio from 2008 to 2022.

Year	Total Liabilities	Change
2022-12-31	ILA3.88 Million ≈ $10.39K	+436.84%
2021-12-31	ILA722.00K ≈ $1.94K	-83.10%
2020-12-31	ILA4.27 Million ≈ $11.45K	+9.23%
2019-12-31	ILA3.91 Million ≈ $10.49K	+278.61%
2018-12-31	ILA1.03 Million ≈ $2.77K	-86.78%
2017-12-31	ILA7.81 Million ≈ $20.94K	-0.32%
2016-12-31	ILA7.84 Million ≈ $21.01K	-5.69%
2015-12-31	ILA8.31 Million ≈ $22.28K	-19.38%
2014-12-31	ILA10.31 Million ≈ $27.63K	+4.41%
2013-12-31	ILA9.87 Million ≈ $26.46K	+34.76%
2012-12-31	ILA7.33 Million ≈ $19.64K	-8.25%
2011-12-31	ILA7.98 Million ≈ $21.40K	-0.04%
2010-12-31	ILA7.99 Million ≈ $21.41K	+14.84%
2009-12-31	ILA6.96 Million ≈ $18.65K	+100.61%
2008-12-31	ILA3.47 Million ≈ $9.29K	--

About Hadasit Bio

TA:HDST Israel Biotechnology & Medical Research

Market Cap

$1.78 Million

ILA665.31 Million ILA

Market Cap Rank

#30221 Global

#441 in Israel

Share Price

ILA60.00

Change (1 day)

+9.09%

52-Week Range

ILA30.00 - ILA83.00

All Time High

ILA2847.77